Approval · Notice of Compliance 11333 · 2010
MORPHINE SR: Notice of Compliance 11333
Issued April 29, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11333
- Date
- April 29, 2010
- Company
- Public Benefits PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- MS CONTIN (Purdue Frederick)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MORPHINE SR | 02350246 | — |
| MORPHINE SR | 02350254 | — |
| MORPHINE SR | 02350262 | — |
Medicinal ingredients
- MORPHINE SULFATE 15 MG per TAB
- MORPHINE SULFATE 30 MG per TAB
- MORPHINE SULFATE 60 MG per TAB